CARDIOGONIOMETRY – New opportunities in the diagnosis of acute and stable coronary artery diseases
In introduction, Prof. Wessely presented data showing how mortality rates in North America have changed over the past 30 years as a function of the various underlying diseases. As ever, heart disease continues to be the most common cause of death; presently, however, this is being overtaken by cancer. By the year 2025, the number of patients with ischemic heart disease in Germany will rise by approx. 35%, the incidence of cardiomyopathy and heart failure will grow at a similar rate of progression (each expected to increase by approx. 20%). By contrast, the number of congenital heart defects will drop by approx. 10% (Bruckenberger Heart Report 2009). On a global scale, Germany ranks in the middle range of cardiac mortality, while at the same time, exhibiting considerable regional differences with regard to cardiac morbidity (which is markedly better in the federal state of Schleswig-Holstein than Mecklenburg-Vorpommern, for example). On two of his slides, Prof. Wessely illustrated the cost explosion in the cardiovascular sector; while the direct costs in North America will rise only moderately by approx. 50% over the next 20 years, the indirect costs will explode by around 200%.
Download the entire study here:Download